Picture of Akoya Biosciences logo

AKYA Akoya Biosciences Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Akoya Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments21.71711381.283.1
Net Total Accounts Receivable
Net Total Receivables13.26.479.449.7317
Total Inventory
Prepaid Expenses
Total Current Assets40.928.7141112122
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment5.467.021024.521.5
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets89.477.7191176180
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities21.217.227.737.135.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities55.259.669.6117127
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity34.218.112158.653.8
Total Liabilities & Shareholders' Equity89.477.7191176180
Total Common Shares Outstanding